kabutan

Oncolys BioPharma, First Half Net Income Loss Widens, Apr-Jun Net Income Loss Widens

Fri Aug 8, 2025 2:00 pm JST Earnings

4588 Oncolys BioPharma Inc. 【J-GAAP】

Earnings Report

Oncolys BioPharma Inc. <4588> [TSE Growth] announced its financial results in the afternoon session on August 8th (14:00). The net loss (non-consolidated) for the cumulative second quarter of the fiscal year ending December 2025 (January to June) expanded to a loss of 1.31 billion yen (compared to a loss of 0.75 billion yen in the same period last year).

In the most recent three-month period, from April to June (2Q), the net loss expanded to a loss of 0.50 billion yen (compared to a loss of 0.39 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -1338.7% in the same period last year to -1721.4%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Jun, 2023 63 -900 -867 -868 -50.2 ー Aug 4, 2023 J-GAAP
Jan - Jun, 2024 31 -793 -752 -754 -37.0 ー Aug 9, 2024 J-GAAP
Jan - Jun, 2025 28 -1,267 -1,311 -1,313 -52.9 ー Aug 8, 2025 J-GAAP
YoY -9.7% -59.8% -74.3% -74.1% -43.0%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 7, 2025 J-GAAP
Jan - Jun, 2025 Results 28 -1,267 -1,311 -1,313 -52.9 0 Aug 8, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 0 -888 -911 -930 -42.6 0 Feb 7, 2025 J-GAAP
Jul - Dec, 2025 Guidance ー ー ー ー － 0 Feb 7, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 63 -1,929 -1,913 -1,938 -108.9 0 Feb 9, 2024 J-GAAP
Dec, 2024 31 -1,681 -1,663 -1,684 -77.2 0 Feb 7, 2025 J-GAAP
Dec, 2025 Guidance ー ー ー ー － 0 Feb 7, 2025 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 31 -415 -389 -390 -19.1 -1,338.7 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 0 -437 -491 -492 -23.5 -Inf Nov 8, 2024 J-GAAP
Oct - Dec, 2024 0 -451 -420 -438 -20.1 -Inf Feb 7, 2025 J-GAAP
Jan - Mar, 2025 0 -785 -810 -811 -32.7 -Inf May 9, 2025 J-GAAP
Apr - Jun, 2025 28 -482 -501 -502 -20.2 -1,721.4 Aug 8, 2025 J-GAAP
YoY -9.7% -16.1% -28.8% -28.7% -5.7%

Related Articles